GCL
TSVT

Glazer Capital LLC’s 2seventy bio TSVT Stock Holding History

Glazer Capital LLC’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,328,166
Closed -$6.56M – 262
2025
Q1 		$6.56M Buy
+1,328,166
New +$4.22M 0.3% 57

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glazer Capital LLC's TSVT Position: Q2 2025 in Review

Glazer Capital LLC sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 1,328,166 shares — an estimated $6.56M sold.

Glazer Capital LLC first reported a position in TSVT in Q1 2025 and held it in 1 quarter. The position peaked at $6.56M in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Glazer Capital LLC reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Glazer Capital LLC sold 1,328,166 2seventy bio shares in Q2 2025, an estimated $6.56M.
  • Glazer Capital LLC first reported a position in 2seventy bio in Q1 2025 and held it in 1 quarter.
  • Glazer Capital LLC's 2seventy bio position peaked at $6.56M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.